The drug combines diabetes drugs Actos and Amaryl into one pill.
Takeda Pharmaceuticals North America, Duetact's manufacturer, plans to make the prescription drug available later this year.
The drug will come with varying amounts of Actos and Amaryl, and will be available in different strengths.
Both drugs are designed to lower blood sugar, but Actos and Amaryl's active ingredients make them work differently.
Actos focuses on insulin resistance, which is when the body doesn't not respond normally to a hormone that controls blood sugar.
Amaryl increases the pancreas' insulin production.
Possible adverse effects of Duetact include low blood sugar, swelling, weight gain, liver problems, heart failure, and higher risk of death from heart or blood vessel problems.
